Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conferenceseries Ltd: World’s leading Event Organizer

Conference Series Conferences gaining more Readers and Visitors

Conference Series Web Metrics at a Glance

  • 3000+ Global Events
  • 25 Million+ Visitors
  • 25000+ unique visitors per conference
  • 70000+ page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Neurocognitive Disorders 2017

Sessions/Tracks

On behalf of Orgnaizing Committee invites all the participants from all over the world to attend the prestigious Scientific Conference on Cognitive Disorders during Oct 09-10, 2017 at London, UK which encompass Keynote presentations, Oral Presentation, Poster presentations and Exhibitions  

Neurocognitive Disorders 2017 is a global platform to discuss and learn about early detection as well as treatment, care based on Professional standards, and increased research to accomplish cure for all cognitive Disorders.  The conference includes leading international experts in Neurocognitive Disorders hospitals specialists, doctors, research scholars and general practitioners form all over the world.

Neurocognitive disorders can affect memory, concentration, Knowledge, language, view, and social cognition. They interfere extremly with a person’s everyday independence in Major Neurocognitive Disorder, but not so in Minor Neurocognitive Disorder.

Track 1: NEURODEGENERATIVE DISORDERS

  Neurodegenerative disorders are defined by the progressive loss of structure or function of neurons, including death of neurons. Neurodegenerative diseases are incurable, resulting in progressive degeneration and death of neuron cells. Neurodegenerative disorders include Alzheimer’s disease, Parkinson’s disease, Huntington disease, Multiple sclerosis, multiple system atrophy, Corticobasal degeneration, Frontotemporal dementia and posterior cortical atrophy.

Related: Neurology Conferences Neurology Congress Neurocognitive disorders Conferences

9th  International conference on Alzheimer’s disease and Dementia, Oct 16-18, 2017; 3rd International conference on Parkinson’s  disease and Movement disorders  Sept 25-26, 2017, Chicago, USA; .14th World Congress on Neurology and Neurological disorders, Jul 17-18, 2017, Chicago, USA; 3rd International conference on Neurological disorders and Stroke, Apr 24-26, 2017 Dubai, UAE; International Conference on Alzheimer’s and Parkinson’s diseases, Mar 29 –Apr 2, 2017, Vienna, Austria; Alzheimer's Disease International 26-29 April, 2017, Kyoto, Japan; Deciphering Neurodegenerative Disorders  May 23-26 2017, Edinburgh, Scotland; Programming and Reprogramming the brain Apr 03-04 ,2017 Munich, Germany;  Parkinson’s Disease Jun 25-30, 2017, Newry, US.

Related Associations:

American Psychological Association (APA), Vestibular Disorders Association (VDA)American Psychological Society ( APS), American Payroll Association ( APA )Association for Psychological Science (APS)

Track 2: NEUROCOGNITIVE DISORDERS

.Neurocognitive disorders are characterized by decline from an attained level of cognitive functioning mainly when physical changes can be seen to have occurred in brain, such as after neurological and mental illness, drug use, or brain injury. Neurocognitive disorders involve impairments in cognitive abilities such as memory, problem solving, and perception. Neurocognitive disorders (NCDs) are a category of conditions that include dementia, amnesia, Mild cognitive impairment, Attention deficit hyperactive disorder.

Related: Neurology Conference | | Neurology Congress  | Neurocognitive disorders Conference

3rd   International Conference on Parkinson’s Disease and Movement Disorders, Sep 25-26, 2017 Chicago, USA; 11th  World Congress on Neurology and Therapeutics, Mar 27-19,2017 Madrid, Spain; 4th  International Conference on Neurodegenerative disorders and Stroke, July 05-06, 2017, Frankfurt, GERMANY; 14th  World Congress on Neurology and Neurological Disorders, July 17-18, 2017, Chicago, USA; 13th  International Conference on Neurology and Neurosurgery, June 19-21, 2017, Paris, FRANCE 2nd  International Brain Stimulation Conference Mar 5-8, 2017,  Barcelona, Spain; British Neuroscience Association (BNA) Festival of Neuroscience 2017 Apr 10-13, 2017,   Birmingham, United Kingdom; Gottingen 2017 / 12th  Gottingen meeting of the German Neuroscience Society Mar 22-25,  2017,  Gottingen, Germany; Alzheimer’s disease and Dementia Conference Oct 29-31,2017, Brussels, Belgium; Alzheimer's Association International Conference July 16-20, 2017 London, United Kingdom.

Related Associations:

 Alzheimer’s North Carolina (ANC),  Bright Focus Foundation (BFF), Lewy Body Dementia Association, Inc. (LBDA), Association for Fronto temporal Degeneration (AFTD), Alzheimer’s Associatio(AA), Alzheimer’s Foundation of America( AFA)

 Track 3: PSYCHIATRIC BRAIN

Psychiatric disorders, including depressionschizophrenia, and bipolar disorder, affect millions of people around the globe.  psychiatric disorder, is diagnosed by a mental health professional of a behavioural or mental pattern that may cause suffering or a poor ability to function in life .In this session we will be discussing about Schizophrenia, Psychosis, Mood disorder, Adjustment disorder, Psychogenic amnesia, Somatic symptom disorder, Major depressive disorder, Delusional disorder and Stereotypic movement disorder.

Related: Neurology Conferences Neurology Congress Neurocognitive disorders Conferences

3rd  International Conference on Neurological disorders and Brain Injury, Apr 18-19, 2017, London, UK; 13th  International Conference on Neurology and Neurosurgery, June 19-21, 2017 Paris, FRANCE; 6th  World Congress Addiction disorders  and Addiction therapy, Aug 29-31, 2017, Prague, Czech Republic; 12th International Conference on Neurology and Neurophysiology  Mar  18-20, 2017, Munich, Germany ; 11th  World Congress on Neurology and Therapeutics, Mar 27-29, 2017, Madrid, SPAIN; International Brain Stimulation Conference Mar 5 - 8, 2017, Barcelona, Spain; Royal College of Psychiatrists Eating disorders faculty spring Conference May 12th , 2017, Liverpool, UK; International Conference on Trauma and Mental Health, May 21st, 2017, Jerusalem,  Israel; 5th International Neuropsychiatric pula congress, May 24, 2017 Pula Croatia; Argentine psychiatric association 32nd  annual Congress, Apr 26-29, 2017,  Mar del Pata, Argentina.

Related Associations :  

World Psychiatric Association (WPA), National Institute of Mental Health (NIH), American Psychiatric Association (APA), Association of Psychiatry‎( AP)

 Track 4 : MOVEMENT DISORDERS

Movement disorders can be defined as neurologic syndromes in which either an excess of movement or a paucity of voluntary and automatic movements, unrelated to weakness or spasticity.  Movement disorders are divided into two major categories: 1. Hyperkinetic  movement disorders. 2. Hypokinetic movement disorders.

Related: Neurology Conference | | Neurology Congress  |   Neurocognitive disorders Conference

3rd  International Conference on Parkinson’s Disease and Movement Disorders, Sep 25-26, 2017, Chicago, USA; 3rd  International Conference on Neurological disorders and Brain Injury, Apr18-19, 2017, London, UK; 18th  Neurology and Neurosurgery Conference, Nov 13-15, 2017, Athens, Germany; 9th  International Conference on Alzheimer’s disease and Dementia, Oct 16-18, 2017, Rome, Italy; 20th  Annual Meeting on Neurology and Neurosurgery, Nov 27-27, 2017, Dubai, UAE;  Movement BrainBody cognition Jul 9-11, 2017, Oxford, UK; 19th  International conference on Parkinson’s Disease and Movement Disorders, May 25-26, 2017, London, UK; Perceptorship of Movement disorders Apr  06th , 2017, Cairo, Egypt; Parkinson’s disease and other Movement disorders, Apr 07-08, 2017,Yeravan,  Armenia; Basic course in movement disorders 19th , 2017, Lagos, Nigeria.

 

Related Associations :International Parkinson and Movement Disorder Society (IPMDS), Movement Disorder Society(MDS), Movement Disorder Society of Australia(MDSA), World Parkinson Congress(WPC), Association of psychosis and movement disorders in the elderly(APMD).

 Track 5: SPINALCORD DISORDERS

Spinal cord disorders can cause permanent severe neurologic disability. For some patients, such disability can be avoided or minimized if evaluation and treatment are rapid.  Spinal cord disorders include cervical myelopathy, Spinal stenosis, Central cord syndrome, Spinal cord tumour, Syrengomyelia, Transverse myelitis and Cauda equina syndrome.

Related: Neurology Conferences Neurology Congress Neurocognitive disorders Conferences

2nd  International Conference on Spine and Spinal disorders, Jul 24-26, 2017, Rome, ITALY; 3rd  International Conference on Central Nervous system disorders and Therapeutics, Oct 02-04, 2017, Vienna, Austria; 9th  International Conference on Alzheimer’s disease and Dementia, Oct 16-18, 2017, Rome, Italy; 20th  International Conference on Neuroscience and Neurochemistry, Feb26-27, 2017, Berlin, Germany; 3rd  International Conference on Neurological disorders and Brain Injury,  Apr18-19, 2017, London, UK; 11th  FENS Forum of Neuroscience07-11 Jul Berlin, Germany; 19th  International Neuroscience Winter Conference, Mar 26-28, 2017, Solden, Astria; ISCT 2017 London Annual Meeting  May 3-6, 2017, London, UK; AD/PD 2017: 13th International Conference on Alzheimer'sParkinson's Apr 29–02,  2017, Vienna, Austria; British Neuroscience Association (BNA) Festival of Neuroscience 2017 Apr 10-13, 2017,  Birmingham, United Kingdom.

Related Associations:

United Spinal Association(USA), Spinal Cord Injury Associations and Organizations(SCIOA), United Spinal Association(USA)National Spinal Cord Injury Association (NSIA), American Association of Spinal Cord Injury Nurses (AASIN)

 Track 6: BRAIN DISORDERS

Brain is a part of nervous system, which also includes the spinal cord and a large network of nerves and neurons. When brain is damaged, it can affect many different things, including memory, sensation, and even personality. Tumours form in the brain and can be very dangerous.  They can be either malignant (cancerous) or benign (noncancerous).  Brain disorders include Meningitis, Encephalitis, Brain abscess, Traumatic brain injury, Seizures.

Related : Neurology Conference | | Neurology Congress  |  Neurocognitive disorders Conference

5th  International Conference on Brain disorders and Therapeutics, Nov 6-8, 2017, Madrid, Spain; 3rd  International Conference on Neurological disorders and Brain Injury, Apr 18-19, 2017, London, UK; 2nd  International Conference and Exhibition of Dual Diagnosis, May 18-19, 2017, Munich, Germany; 12th  International conference on Neurology and Neurophysiology, May 18-20, 2017, Munich, Germany; 2nd  International conference on Neuroimaging and Interventional Radiology, Oct 30- Nov 01, 2017, San Antonio, USA;   Neurology and Brain disorders Jun 26-27, 2017, Valencia, Spain; 4th  International Conference on Brain disorders and Brain injury Aug 14-16, 2017, Toronto, Canada; 3rd  Neurological disorders Summit, Jul 06-08, 2017, San Francisco, USA; 19th  International Conference on Parkinson’s Disease and Movement Disorders, May 25-26, 2017, London, UK; Programming and Reprogramming the brain Apr 03-04, 2017, Munich, Germany.

Related Associations :

National Institute of Mental Health (NIMH),  National Alliance on Mental Illness (NAMI),National Institute of Neurological dis orders and Stroke (NINS), American Academy of Neurological and Orthopaedic Surgeons (AANOS), American Academy of Neurology (AAN).

Track 7: PERIPHERAL NERVOUS SYSTEM DISORDERS

  Peripheral nervous system disorder occurs when peripheral nerves malfunction because they are damaged or destroyed. This disrupts nerves normal functioning. In this session we will be discussing about Neuropathy, Carpal tunnel syndrome, Diabetic neuropathies, Postherpatic neuralgia, Thoracic outlet syndrome, Sciatica and Autonomic neuropathy.

Related: Neurology Conferences Neurology Congress Neurocognitive disorders Conferences

3rd  International Conference on Neurological Disorders and Brain Injury, Apr 18-19, 2017, London, UK; 14th  Neurology and Neurological disorders Conference, July 17-18, 2017, Chicago, USA; 18th  Neurology and Neurosurgery Conference, Nov 13-15, 2017, Athens, Germany; 15th Neurology Congress, Aug 29-31, 2017, London, UK; 2nd  International Conference and Exhibition of Dual Diagnosis, May 18-19, 2017, Munich, Germany; 3rd  International Conference on Neurological disorders and stroke, Apr 24-26, 2017,  Dubai, UAE; British Neuroscience Association (BNA) Festival of Neuroscience 2017, Apr 10-13, 2017, Birmingham, UK; 2nd  International Brain Stimulation Conference, Mar 5-8, 2017,  Barcelona, Spain; Perceptorship of Movement disorders Apr 06th , 2017, Cairo, Egypt; International Brain Stimulation Conference, Mar 5 - 8, 2017, Barcelona, Spain.

Related Associations:

American Chronic Pain Association (ACPA), Foundation for Peripheral Neuropathy (FPN), Neuropathy Association, Muscular Dystrophy Association (MDA), Charcot-Marie-Tooth Association (CMTA), American Society for Peripheral Nerve

 Track 8: SEIZURE DISORDERS

Seizure is an abnormal, unregulated electrical discharge that occurs within the brain’s cortical gray matter and transiently interrupts normal brain function. Seizure disorders include Epilepsy, Myoclonic seizures, Juvenile myoclonic epilepsy, infantile spasms, febrile seizures, Status epilepticus and Petit mal seizures.

Related : Neurology Conference | | Neurology Congress  |  Neurocognitive disorders Conference

3rd International Conference on Epilepsy and Treatment, Aug 31-Sep 01, 2017, Brussels, Belgium; 5th    International Conference on Brain disorders and Therapeutics, Nov 6-8, 2017, Madrid, Spain; 18th  Neurology and Neurosurgery Conference, Nov 13-15, 2017, Athens, Germany; 15th  Neurology Congress, Aug  29-31, 2017, London, UK; 3rd  International Conference on Epilepsy and treatment Aug 31- Sept 01, 2017,  Brussels, Belgium; 15th European Neurology Congress, Aug 29-31, 2017, London, UK; 3rd  Neurological disorders Summit, July 06-08, 2017, San Francisco, USA; 32nd  International Epilepsy Congress, Sep 02-06, 2017, Barcelona, Spain; International Brain Stimulation Conference, Mar 5 - 8, 2017, Barcelona, Spain; Programming and Reprogramming the brain, Apr 03-04, 2017, Munich, Germany; 2nd  International Brain Stimulation Conference Mar 5-8,  2017, in Barcelona, Spain.

Related Associations  :

The Encephalitis SocietyAmerican Epilepsy Society (AES), Epilepsy and Seizure Association of Manitoba (ESAMEpilepsy Association of Central FloridaEpilepsy Association

Track 9: MIGRAINE AND HEADACHES

Headaches are generally classified into two main types: primary headaches and secondary headaches. A migraine, which is a disabling, recurring headache that frequently occurs only on one side of the head and often accompanied by nausea and sensitivity to light and sound is one type of primary headache. Headache remedies include pain relievers.

Related: Neurology Conferences Neurology Congress Neurocognitive disorders Conferences

2nd International Conference on Neuro Oncology and Neurosurgery, Apr 24-25, 2017, Dubai, UAE; 20th International Conference on Neuroscience and Neurochemistry, Feb 26-27, 2017, Berlin, Germany; 11th International Conference on Vascular Dementia, Feb 22-23,  2018,  Paris, France; 12th  International Conference on Neurology and Neurophysiology, May 18-20, 2017, Munich, Germany; 2nd  International Conference and Exhibition of Dual Diagnosis, May 18-19, 2017, Munich, Germany; American Headache Society  59th Annual scientific meeting, June 8-11, 2017, Boston, US; 2nd  International Brain Stimulation Conference  Mar 5-8, 2017, Barcelona, Spain; International Brain Stimulation Conference Mar 5 - 8, 2017,  Barcelona, Spain.

Related Associations:

National Headache Foundation: (NHF), American Headache Society (AHS), Headache and Migraine Organizations (HMO), American Headache and Migraine Association (AHMA), The National Migraine Association (TNMA), Ontario Headache & Migraine Charity.

Track 10:BRAIN ASSOCIATED COMPLICATIONS

Traumatic brain injury can cause a variety of complications, health effects that are not TBI themselves but that result from it. The risk of complications increases with the severity of the trauma. TBI can cause a variety of problems including physical, cognitive, emotional, and behavioural complications. It includes Traumatic brain injury, subdural hematoma, multiloculated hydrocephalus and impaired consciousness.

Related : Neurology Conference | | Neurology Congress  |  Neurocognitive disorders Conference

5th  International Conference on Brain disorders and Therapeutics, Nov 6-8, 2017, Madrid, Spain;  11th   International Conference on Vascular Dementia,  Feb 22-23, 2018, Paris, France; 13th  Interational Conference on Neurology and Neurosurgery, Jun 19-21, 2017, Paris, France; 2nd  International Conference on Neuro Oncology  and Neurosurgery, Apr  24-25, 2017, Dubai, UAE; 2nd  International Conference on Neuroimaging and Interventional Radiology, Oct 30- Nov 01, 2017 San Antonio, USA; 12th  World Congress on Brain Injury, Mar 29 -  Apr 01 2017, New Orleans, United States; International conference on Neurology and Brain disorders, June 26-28,2017,Valencia,Spain; International Brain Stimulation Conference, Mar 5 - 8, 2017, Barcelona, Spain; Programming and Reprogramming the brain, Apr 03-04, 2017, Munich, Germany; 2nd  International Brain Stimulation Conference Mar 5-8,  2017,  Barcelona, Spain.

Related Associations:

American Brain Tumour Association (ABTA),  Alzheimer's Association Hydrocephalus Association,

Track 11: NEUROLOGY NURSING

Neurological Nursing is a very challenging nursing specialty dealing with assessment, nursing diagnosis, and management of many neurological disorders for which nurses provide patient care. This includes trauma, brain injuries, stroke, seizures, tumours, headaches, infections, and aneurysms, as well as a host of other neurological complexities.

Related: Neurology Conferences Neurology Congress Neurocognitive disorders Conferences

11th  World Congress on Neurology and Therapeutics, Mar 27-29, 2017; 2nd  International Conference on Neuro Oncology and Neurosurgery, Apr 24-25, 2017, Dubai, UAE; 17th Global Neuroscience Conference, Oct 16-17, 2017,  Osaka, Japan; 20th  Annual Meeting on Neurology and Neurosurgery, Nov 27-27, 2017,  Dubai, UAE; 12th  International Conference on Neurology and Neurophysiology, May 18-20, 2017 Munich, Germany;   EGYPTIAN NEUROSURGERY Mar 21- 24 2017, Cairo, Egypt; 3rd  Neurological disorders Summit, Jul 06-08, 2017, San Francisco, USA; Programming and Reprogramming the brain Munich, Germany; International Brain Stimulation Conference Mar 5 - 8, 2017,  Barcelona, Spain; European Neuroconvention June 7-8, 2017, London, UK.

Related Associations:

American Association of Neuroscience Nurses (AANN) Neuroscience Nursing (NN),Canadian Association of Neuroscience Nurses(CANNBritish Association of Neuroscience Nurses(BANN)American Association of Nurse Practitioners(AANP).

 Track 12: NEUROPHARMACOLOGY

 Neuropharmacology is the study of how drugs affect cellular function in the nervous system, and the neural mechanisms through which they influence behaviour. There are two main branches of neuropharmacology: behavioural and molecular. It includes Neurological disorders such as  painNeurodegenerative diseases such as Parkinson's disease and Alzheimer's disease, psychological disorders, addiction, and many others.

Related: Neurology Conference | | Neurology Congress  |  Neurocognitive disorders Conference

5th  International Conference and Exhibition on Pharmacology and Ethno pharmacology, Mar 23-25, 2017,  Orlando, USA; 11th  World Congress on Neurology and Therapeutics, Mar 27-29, 2017, Madrid, SPAIN; 12th  International Conference on Neurology and Neurophysiology, May 18-20, 2017, Munich, Germany; 17th  Global Neuroscience Conference, Oct 16-17, 2017, Osaka, Japan; 5th  International Conference on Brain disorders and Therapeutics, Nov 6-8, 2017, Madrid, Spain; World Congress On Neurology And Brain Disorders, Sep 4- 6, 2017,Milan,Italy; 23RD  WORLD CONGRESS OF NEUROLOGY Sep 16-21, 2017, Tokyo, Japan; 2nd  International Brain Stimulation Conference  Mar 5-8, 2017,  in Barcelona, Spain; Movement Brain, Body cognition, Jul 9-11, 2017, Oxford, UK; International Brain Stimulation Conference, Mar 5 - 8, 2017, Barcelona, Spain.

Related Associations:

ASPET NeuropharmacologyThe British Association for Psychopharmacology (BAP), European Society of Neuropharmacology

Track 13: NEUROTHERAPEUTICS

It s an older term for the treatment of disorders that affect the nervous system which psychological, psychiatric, and nervous disorders. Neurotherapeutics is a quarterly peer-reviewed medical journal covering research on experimental treatments of neurological disorders. It includes Stem cells and treatment, Nerve injury and repair Clinical Case report, Neurogenesis, cell and gene based approach and Neurotransmitter release and cell repair.       

Related: Neurology Conferences Neurology Congress Neurocognitive disorders Conferences

 3rd  International Conference on Central Nervous system disorders and Therapeutics, 0ct 02-04, 2017, Vienna, Austria; 11th  World Congress on Neurology and Therapeutics, Mar 27-29, 2017,  Madrid, SPAIN; 15th  European Neurology Congress, Aug 29-31,  2017, London, UK; 3rd  International Conference on Neurological disorders and Brain Injury, Apr 18-19, 2017,  London, UK; 11th  Annual Pain and Migraine Therapeutics Summit, Sept 27-28,  2017, San Diego, US; 2nd  International Brain Stimulation Conference Mar 5-8, 2017,  in Barcelona, Spain; 3rd  Neurological disorders Summit, Jul 06-08, 2017, San Francisco, USA; Royal College of PsychiatristsEating disorders faculty spring Conference May 12th , 2017,  Liverpool, UK.

  Related Associations:

American Society for Experimental Neurotherapeutics (ASEN), Neurologist Association‎,  National Institute of Mental Health (NIMH), National Institute of Neurological Disorders and Stroke (NINDS), National Center for Complementary and Alternative Medicine (NCCAM).

About Conference

ConferenceSeries Ltd invites all the participants from all over the world to attend ‘Neurocognitive Disorders 2017 during October 09-10, 2017 at London, UK which includes prompt keynote presentations, Oral talks, Poster presentations and Exhibitions.

Neurocognitive disorders includes Alzheimer’s disease, is one of the biggest global public health challenges facing our generation. Worldwide, at least 46 million people are living with dementia this number is expected to double by 2030 and more than triple by 2050 to 116 million. Much of the increase will be in developing countries like Western Europe and North America. Already 62% of people with dementia live in developing countries. Today, over 35 million people worldwide currently live with the condition. This number is expected to double by 2030 and more than triple by 2050 to 116 million. No treatments available to slow or stop the brain damage caused by Alzheimer’s disease, several medications can temporarily help improve the symptoms of dementia for some people. In two decades, it is estimated that 1.4 million Canadians will have dementia, costing the economy almost $300 billion per year. Globally, dementia cost $600 billion a year.

The term Dementia describes a loss of mental ability (cognitive impairment) associated with gradual death of brain cells. Vascular Dementia can be caused by a number of different diseases, usually neurodegenerative diseases, such as Alzheimer's disease, front temporal dementia and dementia with Lewy bodies. Vascular dementia is caused when the brain's blood supply is restricted or stopped, leading brain cells to die.

Delirium is defined as a transient, usually reversible, cause of cerebral dysfunction and manifests clinically with a wide range of neuropsychiatric abnormalities. It can occur at any age, but it occurs more commonly in patients who are elderly and have compromised mental status.

Delirium occurs in 30% of those in emergency departments. Occurrence rates vary from 11-42% and it is the most common complication of hospitalization in the elderly population. The incidence is also higher in those with pre-existing cognitive impairment. The prevalence is higher in patients with malignancy and HIV. Despite these facts, delirium remains under diagnosed and poorly managed - only 20-50% is recognized by healthcare professionals.

Why to attend?

Neurocognitive disorders 2017 will provide an opportunity for all stakeholders working on Alzheimer’s disease and Dementia to talk about their work. Neurocognitive disorders will congregate renowned speakers, principal investigators, experts, neurologist’s and Dementia researchers from both academia and health care industry will join together to discuss their views and research. The conference will be comprised of sessions by world class experts in the field of neurology. In Neurocognitive disorders international symposiums, B2B meetings, international workshops will also be organized to discuss the specific topics in the field of Dementia and Neurology.

Target Audience:

  • Neurologists and Directors
  • Physicians
  • Neuroscientists
  • Specialists
  • researchers
  • Health care professionals
  • Professors
  • Industrial Experts
  • Neurosurgeons
  • Psychiatrist
  • Nutritional Scientists
  • Lecturers and Students from Academia in the study of Dementia
  • Students from Academia in the research of Neurology

 

Market Analysis

It is our pleasure to welcome you to the Neurocognitive disorders 2017 to be held in London, UK from October 09-10, 2017.

The organizing committee is gearing up for an exciting and informative program on a variety of topics, poster presentations and various programs for participants from all over the world. Unsurpassed substantiation cure for Neurocognitive disorders clearly shows that the close association of families and careers in the care of their loved ones is key to improving early revealing of Vascular Dementia, renewal to a healthy weight and sustaining long term wellbeing.

This conference will increase knowledge, provide support, assist learning and allow to seek out applicable services and to develop the best environment to support recovery from these complex and devastating diseases.

Market Analysis

Neurocognitive disorders are characterized by decline from an attained level of cognitive functioning mainly when physical changes can be seen to have occurred in brain, such as after neurological and mental illness, drug use, or brain injury. Neurocognitive disorders (NCDs) are a category of conditions that include dementia, amnesia, Alzheimer’s disease, Mild cognitive impairment, Attention deficit hyperactive disorder, Hallucinogen persisting perception disorder, cerebellar cognitive affective syndrome, post-operative cognitive dysfunction, HIV associated neurocognitive disorder.

Alzheimer’s disease is the most common form of dementia accounting for 50% to 70% of all cases. It mostly occurs in the older people who are 65 years and above. Moreover, growing awareness level regarding its symptoms, such as partial dementia, is projected to boost the demand. Currently, there are an estimated 4 million individuals with dementia in the USA with more than 100 000 deaths annually .The global market for Alzheimer’s disease reached $10.2 billion in 2012. The market is expected to decrease to $9.5 billion in 2017 for a CAGR of -1.5%.

The Alzheimer's Association funds independent investigators worldwide, they have awarded over $335 million to more than 2,250 projects. The global cost of Alzheimer’s and dementia is estimated to be $605 billion, which is equivalent to 1% of the entire world’s gross domestic product.

Aggregate Cost of Care by Payer for Americans Age 65 and Older with Alzheimer‘s Disease and Other Dementias: Medicare $113 Billion, Medicaid $41 Billion, Out of pocket $44 Billion, Other $29 Billion.

Dementia is widely considered the second most common cause of dementia after Alzheimer's disease, accounting for 10 percent of cases. Many experts believe that vascular dementia remains underdiagnosed like Alzheimer's disease even though it's recognized as common. The global market for treatments for syndromes of dementia and movement disorders was valued at 10.5 billion in 2011 and should reach $11.1 billion in 2012. Total market value is expected to reach $16.7 billion in 2017 after increasing at a five-year compound annual growth rate (CAGR) of 8.5%.

Amnestic Disorders are a group of disorders that involve loss of memories previously established, loss of the ability to create new memories, or loss of the ability to learn new information.1 In general, Amnestic Disorders are caused by structural or chemical damage to parts of the brain.

People who suffer from Amnestic Disorders usually experience difficulty recalling events that happened in the past or facts they have learned prior to diagnosis. This type of amnesia is known as retrograde amnesia. Some people may also experience symptoms of anterograde amnesia, which involves the inability to learn new facts or retain new memories.

The global amnesia therapeutics market was worth $112m in 2011, and is forecast to grow at a Compound Annual Growth Rate (CAGR) of 3.5% to reach $147m by 2019. This growth is primarily attributed to the increase in the general population and diagnosis rate across the seven major markets (the US, the UK, Japan, Germany, Spain, Italy and France).

Other Companies

Alter G Inc.

 Hocoma

Bioxtreme Robotics Rehabilitation

Instead Technologies

Touch Bionics

MediTouch

Kinova

Ekso Bionics

Kinestica

Kinetic Muscles

WHY LONDON

London is the political, economic and cultural capital of Britain, and its world class tourist attractions are renowned across the globe. The Greater London area is bursting with attractions for visitors of all ages. The river Thames runs through the heart of London, from Richmond in the west, through the central London borough of Westminster, to Greenwich in the east. London river cruises and river buses are a great way to see the city. About one third of London is devoted to parks and open spaces, so there are plenty of places to relax on fine days. London is incredibly well-connected, with five international airports and the high-speed Eurostar rail link. More than 50 countries are within a three-hour flight time and 310 international destinations have direct links to London. t is one of the world's leading financial centres and has the fifth- or sixth-largest metropolitan area GDP in the world. It is the world's most-visited city as measured by international arrivals and has the world's largest city airport system measured by passenger traffic. There are about 15 Universities in and around London which are working in the field of Neurological disorder. Around 1000 neurologist, psychiatrist and neurosurgeons are working exclusively on Neurological disorder in London.

Top hospitals in the World 

The neurology and neurosurgery category consists of 1358 hospitals

The full list of the top 10 hospitals in the United States for neurology and neurosurgery is as follows:

Mayo Clinic, Rochester, Minnesota

New York–Presbyterian University Hospital of Columbia and Cornell, New York City

Johns Hopkins Hospital, Baltimore, Maryland

Massachusetts General Hospital, Boston

University of California–San Francisco Medical Center

Cleveland Clinic, Ohio

University of California–Los Angeles Medical Center

New York University Langone Medical Center, New York City

Hospitals of the University of Pennsylvania–Penn Presbyterian

North-western Memorial Hospital, Chicago

Top hospitals in Europe

Klinik Pyramide Am See

Clinique Générale-Beaulieu

Klinik Hirslanden

University Hospital Hamburg-Eppendorf

J.W Goethe University Hospital

Hirslanden Clinique La Colline

Lucerne Health

Hirslanden Klinik Aarau

J.W Goethe University Hospital

Top hospitals in UK

St Dominics Hospital

National Hospital for Neurology and Neurosurgery

Wellington Hospital

Royal Marsden Hospital

Top hospitals in London

Kings College Hospital

The National Hospital for Neurology and Neurosurgery

The Royal Free

Bart’s and the London Centre for Neurosciences

St George's Hospital

The Wellington Hospital

The London Spinal Injuries Unit

Stoke Mandeville Hospital

St Mary's Hospital

The London Gamma Knife Centre

Top Universities in the World

Harvard University

University College London

University of California--San Francisco

Stanford University

Massachusetts Institute of Technology

Johns Hopkins University

University of California--Los Angeles

University of California--San Diego

Columbia University

University of Oxford

Top Universities in the Europe

University of Cambridge

University College London

Max Planck Society

University of Oxford

King;s College London

University of Edinburgh

Imperial College London

University of Bonn          

University of Amsterdam

University of Briston

Top Universities in the UK

 University of Sheffield

 Plymouth University

 Bournemouth University

  Keele University

  NottinghamTrentUniversity
 Oxford Brookes University

 University Of Birmingham

 UCL (University College London)

 University Of Edinburg

Universities in London

University of Greenwich

University of West London

Imperial College London

Birkbeck University

Kingston University

University College London- UK

King college London –UK

Brunel University London

City University London

Queen Mary, University of London

Associations in the World

Alzheimer’s Association

Alzheimer’s Foundation of America

World Psychiatric Association

National Institute of Mental Health 

National institute of Neurological disorders and Stroke

Epilepsy and Seizure Association of Manitoba

The National Migraine Association

American Association of Neuroscience Nurses

European Society of Neuropharmacology

National Institute of Neurological Disorders and Stroke (NINDS)

Associations in UK

Royal Society of London

Alzheimer's Society

Migraine Trust

International Headache Society

Huntington's disease Association

Brain tumour organizations

National Brain Tumour Society

British neuroscience association

Association for Infant Mental Health

National Association for Mental Health

The Brain injury association

The Neuro Association

Associations in London

Neuro foundation Brain Injury Rehabilitation Trust

Royal Society of London

Alzheimer's Society

Migraine Trust

International Headache Society

Huntington's disease Association

Brain tumour organizations

National Brain Tumour Society

The Neuro Association

 

To Collaborate Scientific Professionals around the World

Conference Date October 09-10, 2017

For Sponsors & Exhibitors

sponsors@conferenceseries.com

Speaker Opportunity

Supported By

All accepted abstracts will be published in respective Conferenceseries International Journals.

Abstracts will be provided with Digital Object Identifier by